Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Santen SAS

Home Clinical Trial Sponsors and OrganizationsSanten SAS

Santen SAS

ACTIVE

Francewww.santen.eu/frSubsidiary

Part of SANTEN PHARMACEUTICAL CO., LTD.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

27

14 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

14

51.9%

Phase 3

5

18.5%

Phase 2

3

11.1%

Not Applicable

2

7.4%

Phase 4

1

3.7%

Trial Status Distribution

Active, not recruiting

14

51.9%

Completed

11

40.7%

Recruiting

2

7.4%

Clinical Trials

Trials sponsored by this organization (27)

PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group

Mar 2026112 participants

Observational Survey Study on the Impact of Myopia and Its Complications on Quality of Life.

Jul 2025344 participants

LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of Acquired Blepharoptosis.

Dec 2024234 participants

3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis

Sep 202183 participants

A three-year study to explore the long-term evolution of sign and symptoms of severe Dry Eye Disease in patients receiving IKERVIS® (1mg/ml ciclosporin) eye drops.

Active, not recruiting

Jun 2021350 participants

International clinical study comparing the efficacy and safety of DE-130A with Xalatan® in patients with glaucoma (high pressure inside the eye).

Active, not recruiting

Jun 2021380 participants

3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis

Active, not recruiting

May 202180 participants

International clinical study comparing the efficacy and safety of DE-130A with Xalatan® in patients with glaucoma (high pressure inside the eye).

Active, not recruiting

Mar 2021380 participants

Page 1 of 4

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials27
Approvals
News

Back to Organizations